| Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones S Yakar, NP Nunez, P Pennisi, P Brodt, H Sun, L Fallavollita, H Zhao, ... Endocrinology 147 (12), 5826-5834, 2006 | 180 | 2006 |
| Transcriptional regulation of estrogen receptor-α by p53 in human breast cancer cells SH Shirley, JE Rundhaug, J Tian, N Cullinan-Ammann, I Lambertz, ... Cancer research 69 (8), 3405-3414, 2009 | 139 | 2009 |
| Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma CL Walker, KD Burroughs, B Davis, K Sowell, JI Everitt, R Fuchs-Young Journal of the Society for Gynecologic Investigation 7 (4), 249-256, 2000 | 122 | 2000 |
| Raloxifene is a tissue selective agonist/antagonist that functions through the estrogen receptor HW Cole, DE MAGEE, JD TERMIIW Ann NY Acad Sci 761, 355360, 1995 | 117 | 1995 |
| Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat KD Burroughs, R Fuchs-Young, B Davis, CL Walker Biology of reproduction 63 (5), 1322-1330, 2000 | 110 | 2000 |
| Inhibition of estrogenstimulated growth of uterine leiomyomas by selective estrogen receptor modulators R FuchsYoung, S Howe, L Hale, R Miles, C Walker Molecular Carcinogenesis: Published in cooperation with the University of …, 1996 | 107 | 1996 |
| Dysregulation of IGF-I signaling in uterine leiomyoma KD Burroughs, SR Howe, Y Okubo, R Fuchs-Young, D LeRoith, ... Journal of endocrinology 172 (1), 83-94, 2002 | 97 | 2002 |
| Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo KK De Ostrovich, I Lambertz, JKL Colby, J Tian, JE Rundhaug, ... The American journal of pathology 173 (3), 824-834, 2008 | 84 | 2008 |
| Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium DS Hunter, LC Hodges, PM Vonier, R Fuchs-Young, MM Gottardis, ... Cancer research 59 (13), 3090-3099, 1999 | 77 | 1999 |
| Exercise effects on tumorigenesis in a p53-deficient mouse model of breast cancer LH Colbert, KC Westerlind, SN Perkins, DC Haines, D Berrigan, ... Medicine and science in sports and exercise 41 (8), 1597, 2009 | 72 | 2009 |
| Localization of immunoreactive epidermal growth factor receptor in neonatal and adult rat hippocampus MS Tucker, I Khan, R Fuchs-Young, S Price, TL Steininger, G Greene, ... Brain research 631 (1), 65-71, 1993 | 70 | 1993 |
| Influence of exogenous estrogen receptor ligands on uterine leiomyoma: evidence from an in vitro/in vivo animal model for uterine fibroids DS Hunter, LC Hodges, PK Eagon, PM Vonier, R Fuchs-Young, ... Environmental health perspectives, 829-834, 2000 | 52 | 2000 |
| Effects of raloxifene in a guinea pig model for leiomyomas KB Porter, JCM Tsibris, GW Porter, R Fuchs-Young, SV Nicosia, ... American journal of obstetrics and gynecology 179 (5), 1283-1287, 1998 | 52 | 1998 |
| Regulation of apoptosis in uterine leiomyomata KD Burroughs, K Kiguchi, SR Howe, R Fuchs-Young, D Trono, JC Barrett, ... Endocrinology 138 (7), 3056-3064, 1997 | 51 | 1997 |
| Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells LC Hodges, KD Houston, DS Hunter, R Fuchs-Young, Z Zhang, ... Molecular and cellular endocrinology 196 (1-2), 11-20, 2002 | 47 | 2002 |
| Developmental stage determines estrogen receptor alpha expression and non-genomic mechanisms that control IGF-1 signaling and mammary proliferation in mice J Tian, TR Berton, SH Shirley, I Lambertz, IB Gimenez-Conti, J DiGiovanni, ... The Journal of clinical investigation 122 (1), 192-204, 2012 | 44 | 2012 |
| Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma SD Gamage, ED Bischoff, KD Burroughs, WW Lamph, MM Gottardis, ... Journal of Pharmacology and Experimental Therapeutics 295 (2), 677-681, 2000 | 44 | 2000 |
| An in vivo/in vitro Model to Assess Endocrine Disrupting Activity of Xenoestrogens in Uterine Leiomyoma LC Hodges, DS Hunter, JS Bergerson, R FUCHSYOUNG, CL Walker Annals of the New York Academy of Sciences 948 (1), 100-111, 2001 | 34 | 2001 |
| P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesis R Fuchs-Young, SH Shirley, I Lambertz, JKL Colby, J Tian, D Johnston, ... Breast cancer research and treatment 130, 399-408, 2011 | 29 | 2011 |
| Addressing cancer health disparities using a global biopsychosocial approach D King, P Miranda, B Gor, R FuchsYoung, J Chilton, R Hajek, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2010 | 20 | 2010 |
